Essex County Overdose Deaths — 5-Year Trend
According to the NJ Office of the Chief State Medical Examiner (OCSME): 2024 — 309 suspected OD deaths (preliminary). 2023 — 448 deaths. 2022 — 450 deaths (414 confirmed). 2021 — peak during COVID lockdown. In the first half of 2024, Essex County saw 182 drug deaths compared to 230 in the same period of 2023 — a 21% decline. Essex has consistently led New Jersey in total overdose death counts since the opioid crisis accelerated.
Newark-Specific: Ward-Level Drug Burden
A 2026 peer-reviewed analysis in ResearchSquare mapped Newark's substance use burden by ward and found distinct geographic inequality. Central Ward and South Ward show the highest concentration of drug-related mortality and treatment admissions, driven by concentrated disadvantage, housing instability, and service-delivery patterns. North Ward and East Ward (Ironbound) show lower opioid death rates, which researchers attribute to higher residential stability and social cohesion. West Ward falls in the middle.
Substance Breakdown — What's Actually Killing People
Statewide 2022 confirmed overdose data (NJ-SAMS): Fentanyl — 2,266 deaths (~78% of the 2,914 total). Heroin — 1,082 deaths. Cocaine and stimulants — substantial presence, especially in urban counties. Xylazine — present in approximately 23% of fentanyl powder samples tested by the DEA. Essex County's profile follows the statewide trend, with heavy fentanyl dominance and growing xylazine contamination.
Who Is Dying — Demographics
Statewide 2025 preliminary OCSME data (Q1): of those who died from suspected drug overdoses between January and April 2025, 65% were male, 34% female. By race: 56% White, 27% Black, 14% Hispanic. Peak age group: 35–44, followed by 45–54 and 25–34. Essex County's profile skews somewhat older and more Black than the statewide average, reflecting Newark's demographics.
What's Working (and What Isn't)
Working: Naloxone365 — NJ's free-Narcan-by-mail program launched January 2023, which has dispensed 95,000+ two-dose kits. Harm Reduction Centers, now authorized to distribute xylazine test strips. Expansion of MAT under NJ parity law. Opioid settlement funding ($641M flowing to NJ and its 241 municipalities). Not working at scale: mental health care access (NJ received a 'F' on national parity compliance in 2018, improved since but still gapped). Housing and social services integration with SUD care — a particular issue in Newark's Central and South Wards.
Where Data Comes From
NJ OCSME publishes suspected overdose death counts monthly at NJOAG.gov. NJ-SAMS (Substance Abuse Monitoring System) publishes treatment admission data annually. NJ Department of Health maintains the overdose data dashboard at nj.gov/health/populationhealth/opioid. Research-grade analyses are published through peer-reviewed outlets like ResearchSquare, the New England Journal of Medicine, and the American Journal of Public Health.